Supportive Oncology/Cancer Care Delivery Trials
Every treatment that has ever made a difference in cancer care was once a part of a clinical trial. MUSC Hollings Cancer Center is committed to offering the best treatments available today while searching for even better ones for the future. Ask your doctor if a clinical trial is right for you.
STUDY26884
AYA Access: An Enhanced eHealth and Chat-Bot Enabled Delivery Model for Clinical Genetic Services in Community AYA Cancer Patients
To evaluate the efficacy of an enhanced eHealth and chatbot enabled delivery model to increase uptake of genetic counseling. To evaluate the efficacy of an enhanced eHealth and chatbot enabled delivery model to increase uptake of genetic testing.
Study InformationSTUDY26932
LiveWell: An Adapted Dialectical Behavioral Therapy Skills Training Protocol for Patients Living with Metastatic Lung Cancer
To evaluate the feasibility and acceptability of LiveWell. To evaluate preliminary efficacy of LiveWell to reduce psychological distress (primary outcome) and improve psychological well-being, symptom burden, and quality of life (secondary outcomes) in patients with metastatic lung cancer compared to usual care. Exploratory: To evaluate emotion regulation as a moderator.
Study InformationSTUDY27022
Evaluating the Impact of TrialTalk™ to Foster Equitable Cancer Care Delivery and Clinical Trial Participation
Examine TrialTalk effectiveness by examining the changes in clinical tiral accrual from baseline by race and ethnicity among enrolled providers and at the institution level up to 12 months post- implementation. Examine the implementation outcomes of TrialTalk such as adoption, penetration, fidelity, feasibility, and acceptability with different stakeholder groups.
Study InformationSTUDY27244
NRG-CC015: Harnessing E-mindfulness Approaches for Living After Breast Cancer - HEAL ABC
To determine the efficacy of Mindful Awareness Practices (MAPs) live online (LO) relative to the meditation only (MO) control group on depressive symptoms, as indicated by the difference in CES-D change score from baseline to post-intervention between the intervention and control groups. To determine the efficacy of Mindful Awareness Practices (MAPs) App relative to the meditation only (MO) control group on depressive symptoms, as indicated by the difference in CES-D change score from baseline to post-intervention between the intervention and control groups.
Study InformationSTUDY27547
S2417CD: A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention Called Current Together after Cancer (CTAC) to Promote Guideline-Concordant Colorectal Cancer Surveillance
To evaluate whether the patients randomized to the Current Together After Cancer (CTAC) intervention website compared to the CTAC control website have higher rates of guideline concordant colorectal cancer (CRC) surveillance at 12 months after registration.
Study InformationSTUDY27901
Examining emotional health and symptom needs in long-term cancer survivors living with likely incurable cancer: Administrative Supplement to IMPACT R01
1. To examine emotional health and symptom burden survivorship needs and preferences for psychosocial intervention delivery in long-term cancer survivors living with likely incurable cancer (LTCS-ILLIC)
Study InformationSTUDY28303
Safely Optimizing Body Weight with TCMCB07 in Patients with Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy
To evaluate the effect of B07 relative to placebo on body weight over 12 weeks in newly diagnosed metastatic colorectal cancer patients. To evaluate the safety of B07 relative to placebo through Week 12.
Study InformationSTUDY28498
A Qualitative Study Exploring the Lived Experiences of Adolescent and Young Adult Head and Neck Cancer Survivors: A Semi-Structured Interview
To explore the lived experiences of adolescent and young adult (AYA) survivors of head and neck cancer (HNC), focusing on how diagnosis, treatment, and survivorship have shaped their daily lives, identities, and social relationships. To describe and interpret common psychosocial, functional, and existential challenges encountered during survivorship, including issues related to communication, eating, appearance, and reintegration into peer groups.
Study InformationSTUDY29217
Optimizing Clinical Screening for Body Image Distress Among Head and Neck Cancer Survivors: Implementation of a Short Form of the IMAGE-HN Questionnaire
The overarching goal of this study is to determine the most effective and practical approach to screen for BID among HNC survivors in the clinical setting. This includes identifying efficient methods that integrate seamlessly into routine clinic workflows while accurately detecting patients with clinically significant BID, enabling timely referral to appropriate psychosocial interventions.
Study Information